Dr. Paul Offit: Myocarditis as a Consequence of Taking the mRNA Vaccine Was ‘a Very Small Price to Pay’

TRANSCRIPT:

OFFIT: "They authorize, then, through Emergency Use Authorization, this vaccine, but you’re always, always waiting for the other shoe to drop, and it did drop. I mean, with the — the mRNA marinade vaccines, there was myocarditis, which is inflammation of the heart muscle, primarily in boys 16 to 29 years of age, primarily after the second dose, primarily within four days, but generally was transient and self-resolving, so it really wasn’t that bad. That was a very small price to pay, I think, for that vaccine. But you had J&J's vaccine, which we reviewed in February of 2021, the adenovirus  vector vaccine, and that was again about a 30,000-person study. So you saw 15,000 people got that vaccine, then millions of people got it, and it was found to be the cause of clotting, including severe clotting, including clotting in the brain that ultimately drove that vaccine off the market by March of 2023. And everybody looks at that story and they say, 'How did you not know that? How did you recommend something like that, which now has caused deaths in some people? How could you not know that?' And people then lose trust, which is in part, sort of, why I wrote this book, because I just think people have to have realistic expectations of the fact that you’re going to learn as you go, which everybody agrees with, except when it comes to, you know, any personal experience they've had."